» Authors » Jens Peter Klussmann

Jens Peter Klussmann

Explore the profile of Jens Peter Klussmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 164
Citations 1378
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Esser J, Sharma S, Jansen S, Mayer M, Jansen L, Klussmann J, et al.
Laryngorhinootologie . 2025 Feb; PMID: 39900087
No abstract available.
2.
Suchan M, Wuerdemann N, Wagner S, Langer C, Arens C, Johannsen J, et al.
Oral Oncol . 2025 Feb; 162:107209. PMID: 39893876
Introduction: Subgroups with a poorer prognosis exist among patients with human papillomavirus positive oropharyngeal squamous cell carcinoma (HPV-positive OPSCC). This study aims to identify histological and genetic differences within HPV-positive...
3.
Esser J, Sharma S, Jansen S, Mayer M, Jansen L, Klussmann J, et al.
Laryngorhinootologie . 2025 Jan; PMID: 39837543
The aim of this study was to investigate the representation of women in the German-speaking scientific publication landscape of otorhinolaryngology.Authorship was analyzed based on articles published between 2013 and 2023...
4.
Mayer M, Alfarra M, Mollenhoff K, Engels M, Arolt C, Quaas A, et al.
Head Neck Pathol . 2025 Jan; 19(1):1. PMID: 39775177
Purpose: Ultrasound-guided fine-needle aspiration cytology (FNAC) is a widely used diagnostic procedure which facilitates the differentiation of salivary gland lesions. Although the performance of salivary gland FNAC (SG-FNAC) has improved...
5.
Lyu S, Fretter C, Eckel H, Knipper K, Schultheis A, Buttner R, et al.
Oral Oncol . 2025 Jan; 161():107171. PMID: 39756240
Background: The histone gene H2AX and its phosphorylated protein γ-H2AX play a crucial role in the DNA damage response. This study investigates the expression of H2AX mRNA and its phosphorylated...
6.
Schleifenbaum J, Morgenthaler J, Sharma S, Klussmann J, Linde P, Wegen S, et al.
Radiat Oncol . 2025 Jan; 20(1):1. PMID: 39748422
Introduction: Locoregional recurrence (LR) is common in locally advanced head and neck cancer (HNSCC), posing challenges for treatment. We analysed outcome parameters and toxicities for patients being treated with radiotherapy...
7.
Knopf A, Ketterer M, Hoffmann T, Laban S, Berghaus A, Canis M, et al.
Eur Arch Otorhinolaryngol . 2024 Oct; PMID: 39438293
Objective: This retrospective multicenter study aimed to evaluate surgical versus conservative treatment in patients with hypopharyngeal and laryngeal cancer under real world conditions. Methods: This study included 2307 patients diagnosed...
8.
Jansen L, Nachtsheim L, Mayer M, Arolt C, Quaas A, Klussmann J, et al.
Laryngorhinootologie . 2024 Oct; 104(2):87-93. PMID: 39419038
Salivary gland carcinomas are a rare and heterogeneous group of malignant tumors, accounting for 3-6% of all malignant tumors in the head and neck region. The 1-, 3- and 5-year...
9.
Nachtsheim L, Moller L, Oesterling F, Kajueter H, Stang A, Hieggelke L, et al.
Cancer Epidemiol . 2024 Oct; 93:102684. PMID: 39393188
Purpose: This study aims to provide a broad overview of the epidemiology of cancer of the paranasal sinuses (PSC) in Germany. The data include information on incidence, staging, clinicopathological features...
10.
Esser J, Broicher L, Mayer M, Eckel H, Jansen L, Nobis A, et al.
Eur Arch Otorhinolaryngol . 2024 Oct; 282(2):789-795. PMID: 39367222
Introduction: Cholesteatoma, a challenging entity in otologic surgery, necessitates a standardized classification system for effective communication among healthcare providers and consistent reporting of surgical outcomes. The ChOLE Classification System, introduced...